Elevated CXCR4 expression in lung cancer has been correlated with enhanced tumor aggressiveness as well as a poor prognosis in tandem with both enhanced therapy resistance to chemotherapy and ICI therapy (Tajaldini et al., 2023). This evidence concerns the gene CXCR4 and lung carcinoma.